Intranasal alpha-2 agonists for premedication in paediatric patients undergoing surgery

Intranasal dexmedetomedine for premedication in paediatric patients undergoing surgery under general anaesthesia - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088010

Enrollment

Registered

2025-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H660- Acute suppurative otitis media Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Intranasal dexmedetomedine : Intranasal dexmedetomedine 1mcg/kg for premedication 60mins before undergoing planned surgery under general anaesthesia Control Intervention1: Intranasal

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients coming for elective surgery under general anaesthesia. Age between 1 to 12 years both sexes ASA 1 and ASA 2.

Exclusion criteria

Exclusion criteria: Parental refusal for consent ASA grade 3 and higher. Paediatric patients with cardiac problems

Design outcomes

Primary

Measure	Time frame
The sedative effects on the child in the pre operative period and while shifting to OTTimepoint: 20mins	—

Secondary

Measure	Time frame
Pre op, Intra op, post op haemodynamics and saturation. Behaviour and Wake up behavioural score. Behaviour of the child in the pre operative period and while shifting to OTTimepoint: 15mins,30mins,45mins,60mins,75mins,90mins,105mins,120mins	—

Countries

India

Contacts

Public ContactDr Owk Mrunalini

Gayatri vidya parishad institute of health care and medical technology

owkmrunalini@gmail.com8897234462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026